By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Caliper Life Sciences 

68 Elm Street

Hopkinton  Massachusetts  01748  U.S.A.
Phone: 508-435-9500 Fax: 508-435-3439


Caliper Life Sciences (NASDAQ: CALP) is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease. With a keen focus on clinically-relevant experimentation, Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.

Our company represents a community of intelligent, highly-motivated people dedicated to working together as a team to improve the human condition through innovation in life sciences research. We maintain world headquarters in Hopkinton, Massachusetts, and direct sales, service and application-support operations in biopharmaceutically-active countries around the globe. Caliper’s customers and partners include leading pharmaceutical companies like Pfizer, GlaxoSmithKline, Sanofi-Aventis, Novartis, and AstraZeneca, among others.

Key Statistics

Ownership: Public

Web Site: Caliper Life Sciences
Employees: 250
Symbol: CALP

Company News
AQUA(R) Technology Expands to Additional Digital Pathology Platform with Launch of Vectra(TM) 2 from Caliper Life Sciences (CALP), a PerkinElmer, Inc. (PKI) 11/18/2011 10:29:36 AM
PerkinElmer, Inc. (PKI) Completes Acquisition of Caliper Life Sciences (CALP) 11/8/2011 5:59:59 AM
PerkinElmer, Inc. (PKI) to Acquire Caliper Life Sciences (CALP) for $600 Million 9/8/2011 6:55:49 AM
Erasmus University Medical Center in Rotterdam Adopts Automated Target Enrichment Solution from Roche NimbleGen, Inc and Caliper Life Sciences (CALP) for 3,000 Sample Exome Study 9/6/2011 11:37:18 AM
Caliper Life Sciences (CALP) Announces IVIS Spectrum CT 8/31/2011 10:40:48 AM
Caliper Life Sciences (CALP) to Present at Stifel Nicolaus Healthcare Conference 2011 8/25/2011 10:43:38 AM
Caliper Life Sciences (CALP) and Carestream Health, Inc. Settle Lawsuits 8/8/2011 11:55:00 AM
Caliper Life Sciences (CALP) to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable 7/29/2011 10:26:20 AM
Caliper Life Sciences (CALP) Announces CE IVD Mark for LabChip(R) Dx for Clinical Patient Sample Testing 7/26/2011 6:47:39 AM
Caliper Life Sciences (CALP), President and CEO to Ring The NASDAQ Stock Market Opening Bell 7/18/2011 9:59:13 AM